Altavant Sciences GmbH
Records under this name other than the patents Altavant Sciences GmbH holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 10 patents it holds.
Back to Altavant Sciences GmbH
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,718,853 | Localized therapy of lower airways inflammatory disorders with proinflammatory cytokine inhibitors Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,940,683 | Localized Therapy of Lower Airways Inflammatory Disorders with Proinflammatory Cytokine Inhibitors Formerly held In force · High confidence | In force | High confidence | |
| US 11,413,287 | Method for Treating Pulmonary Arterial Hypertension and Associated Pulmonary Arterial Hypertension Lapsed on the fee record Ended Aug 16, 2026 · High confidence | Lapsed on the fee record | Ended Aug 16, 2026 | High confidence |
| US 10,045,988 | Spirocyclic Compounds as Tryptophan Hydroxylase Inhibitors Lapsed on the fee record Ended Aug 14, 2026 · High confidence | Lapsed on the fee record | Ended Aug 14, 2026 | High confidence |
| US 8,637,469 | Rhinosinusitis prevention and therapy with proinflammatory cytokine inhibitors Lapsed on the fee record Ended Jan 28, 2026 · From the USPTO record | Lapsed on the fee record | Ended Jan 28, 2026 | From the USPTO record |
| US 11,203,597 | Crystalline spirocyclic compound, a dosage form containing, a method for using in treatment of disease, and a method for recrystallizing Lapsed on the fee record Ended Dec 21, 2025 · From the USPTO record | Lapsed on the fee record | Ended Dec 21, 2025 | From the USPTO record |
| US 9,750,740 | Spirocyclic Compounds as Tryptophan Hydroxylase Inhibitors Lapsed on the fee record Ended Sep 5, 2025 · High confidence | Lapsed on the fee record | Ended Sep 5, 2025 | High confidence |
| US 11,091,763 | Localized therapy of lower airways inflammatory disorders with proinflammatory cytokine inhibitors Lapsed on the fee record Ended Aug 17, 2025 · From the USPTO record | Lapsed on the fee record | Ended Aug 17, 2025 | From the USPTO record |
| US 9,611,201 | Processes for preparing (R)-1-(5-chloro-[1,1′-biphenyl]-2-yl)-2,2,2-trifluoroethanol and 1-(5-chloro-[1,1′-biphenyl]-2-yl)-2,2,2-trifluoroethanone Lapsed on the fee record Ended Apr 4, 2025 · From the USPTO record | Lapsed on the fee record | Ended Apr 4, 2025 | From the USPTO record |
| US 10,946,018 | Spirocyclic Compounds as Tryptophan Hydroxylase Inhibitors Lapsed on the fee record Ended Mar 16, 2025 · High confidence | Lapsed on the fee record | Ended Mar 16, 2025 | High confidence |